Results 131 to 140 of about 1,424,424 (268)

Retraction: High expression of long noncoding RNA HOTAIRM1 is associated with the proliferation and migration in pancreatic ductal adenocarcinoma

Pathology and Oncology Research
Pathology & Oncology Research Editorial Office
doaj   +1 more source

Predictive and prognostic biomarkers of Bacillus Calmette‐Guérin therapy failure in bladder cancer patients: A systematic review

Molecular Oncology, EarlyView.
High‐risk bladder cancer is typically treated with Bacillus Calmette‐Guérin (BCG), but 30–40% of patients relapse. No FDA‐ or CE‐approved biomarkers currently predict or prognosticate BCG failure. We systematically reviewed the literature and identified 72 eligible studies, revealing several promising biomarkers associated with BCG treatment response ...
Rui Ribeiro‐Pereira, Ana Teixeira‐Marques, Rui Freitas, João A Carvalho, Sara Monteiro‐Reis, Giorgio I. Russo, Rui Henrique, Carmen Jerónimo   +7 more
wiley   +1 more source

Cancer Epidemiology and Decentralization Service Program Initiation: A Cross-Sectional Analysis of Hospital-Based Oncology Admissions and Cancer Service Disparities. [PDF]

Curr Oncol
Jafta Z, Milambo MJP, Chitha WW.
europepmc   +1 more source

Retraction: Case report: A rare case of tumor-to-tumor metastasis: metastatic lobular breast carcinoma to clear cell renal cell carcinoma

Pathology and Oncology Research
Pathology and Oncology Research Editorial Office
doaj   +1 more source

NAPRT loss promotes lung tumor initiation and growth through AKT signaling independently of NAD+ biosynthesis

Molecular Oncology, EarlyView.
Loss of NAPRT promotes lung tumor initiation and growth through a noncanonical mechanism, independent of its role in NAD+ biosynthesis. Mechanistically, NAPRT depletion activates the mTORC2‐driven AKT/β‐catenin signaling axis to enhance clonogenic and invasive phenotypes. Furthermore, lung‐specific Naprt deletion significantly increases tumor burden in
Myung Joon Oh, Ji Yun Jang, Yoon Jeon, Gi‐Cheon Kim, Hwanho Lee, Jooyoung Lee, Ju‐Hwa Kim, Hakhyun Kim, Minjee Kim, Ho‐Keun Kwon, Ho Lee, Hyun Seok Kim   +11 more
wiley   +1 more source

Corrigendum to 'Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after two or more HER2-directed therapies': [ESMO Open Volume 11, Issue 7, July 2026, 107706]. [PDF]

ESMO Open
Kim JW, Park YH, Lee S, Ahn HK, Bae J, Park S, Chae H, Kim JH, Lee KH, Kim MH, Lee KE, Kang MJ, Park IH, Chae YS, Lee GW, Park KU, Lee EM, Park JH, Kim JE, Kim HJ, Kim TH, Oh SY, Ko S, Byun JH, Ha JY, Kwon JH, Lee S, Choi JY, Jung JY, Park KH.   +29 more
europepmc   +1 more source

Learning From Mistakes: Navigating Medical Errors in Oncology From Prevention to Management [PDF]

Journal of Immunotherapy and Precision Oncology
Daniel D. Karp, Jessica A. Osburn, Mohamed A. Gouda   +2 more
doaj   +1 more source

Regulation of the lncRNA NEAT1 by p53‐ΔNp63 crosstalk modulates the DNA damage response and therapeutic efficacy in HNSCC

Molecular Oncology, EarlyView.
In head and neck squamous cell carcinoma (HNSCC) p53 and p63 exert opposite roles on the transcription regulation of the lncRNA NEAT1. Under basal conditions, p53 levels are low and p63 represses NEAT1 expression. Upon genotoxic stress, p53 is rapidly induced, displacing p63 from the NEAT1 promoter leading to NEAT1 transcriptional activation and ...
Sara De Domenico, Veronica La Banca, Silvia D'Amico, Stefano Scalera, Sara Nicolai, Angelo Peschiaroli   +5 more
wiley   +1 more source

Functional outcomes in oncology patients receiving chiropractic care: a retrospective chart review. [PDF]

Support Care Cancer
Siegel S, Szymulanska-Ramamurthy K, Gupta D.   +2 more
europepmc   +1 more source

Retraction: Knockdown of Sox2 inhibits OS cells invasion and migration via modulating Wnt/β-catenin signaling pathway

Pathology and Oncology Research
Pathology and Oncology Research Editorial Office
doaj   +1 more source